4p16.3-15.31 deletion
Copy-numberCNV-lossPathogenicCytoplasmic · predictedCNV-loss — Copy-number deletion — 4p16.3-15.31
Gene-level event
Variant Assessment
Therapeutic Implication · CNV-loss
Clinical Evidence
Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).
Feed this card to Wolfram Intelligence
Download the 4p16.3-15.31 deletion card below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals matched to this CNV-loss copy-number variant and its domain context.
Full Variant Card
4p16.3-15.31 deletion — WFS1 Molecular Atlas Card
Variant type: Copy-number variant (deletion) Region: Chromosome 4p16.3-15.31 (gene-level structural event)
CNV-loss — Copy-number deletion — 4p16.3-15.31
This is a large copy-number deletion spanning 4p16.3-15.31 — a gene-level event causing loss of one copy of this region (wolframin haploinsufficiency or, with a second hit, loss of function). CNVs act by dosage rather than by altering a single residue, so AlphaFold residue mapping, ΔΔG, NMD and AlphaMissense don't apply. Therapeutically these are gene-replacement candidates (restore a working copy); per-residue chaperone/readthrough strategies are not relevant. Confirm breakpoints and gene content against the ClinVar record below.
Clinical evidence
- Classification: Pathogenic
- Review status: no assertion criteria provided
- Associated conditions: See cases
- ClinVar accession: VCV001707444
- Genomic variant: GRCh37/hg19 4p16.3-15.31(chr4:68345-20964575)x1
- Last evaluated: 1/01/01 00:00
Card generated by wolfram-atlas-batch (CNV pipeline) on 2026-06-08T03:03:52.333717Z.
CNVs are gene-level events; WFS1 protein reference UniProt O76024 is not residue-mapped here.